Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2026-03-03 @ 4:42 PM
Study NCT ID:
NCT04869358
Status:
COMPLETED
Last Update Posted:
2025-05-16
First Post:
2021-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab
Sponsor:
Organization: